Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Malaguarnera, Giulia ^a   Gagliano, Caterina ^a   Giordano, Maria ^a   Salomone, Salvatore ^a   Vacante, Marco ^a   Bucolo, Claudio ^a   Caraci, Filippo ^a,b   Reibaldi, Michele ^a   Drago, Filippo ^a   Avitabile, Teresio ^a   Motta, Massimo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN; METFORMIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIET RESTRICTION; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPROLIFERATIVE RETINOPATHY; PREDICTIVE VALUE; PREVALENCE; PROLIFERATIVE RETINOPATHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ADULT; BLINDNESS; BLOOD; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLINDNESS; DIABETIC RETINOPATHY; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED;

EID: 84901365193     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/191497     Document Type: Article

References (18)

1. Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 2007 356 3 213 215 2-s2.0-33846422032 10.1056/NEJMp068177 (Pubitemid 46143224)
2. Rampello L., Vecchio I., Battaglia G., Malaguarnera G., Rampello L., Diabetic neuropathy. Elements of epidemiology and pathophysiology. Acta Medica Mediterranea 2012 3 219
3. Grundy S. M., Benjamin I. J., Burke G. L., Chait A., Eckel R. H., Howard B. V., Mitch W., Smith S. C. Jr., Sowers J. R., Diabetes and cardiovascular disease: a statement for healthcare professionals from the american heart association. Circulation 1999 100 10 1134 1146 2-s2.0-0033533596 (Pubitemid 29416243)
4. Matthews D. R., Stratton I. M., Aldington S. J., Holman R. R., Kohner E. M., Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Archives of Ophthalmology 2004 122 11 1631 1640 2-s2.0-8144221037 10.1001/archopht.122.11. 1631 (Pubitemid 39473407)
5. Malaguarnera G., Gagliano C., Bucolo C., Lipoprotein(a) serum levels in diabetic patients with retinopathy. BioMed Research International 2013 2013 5 10.1155/2013/943505 943505
6. Malaguarnera M., Ferri R., Bella R., Alagona G., Carnemolla A., Pennisi G., Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clinical Chemistry and Laboratory Medicine 2004 42 9 1032 1035 2-s2.0-4744345419 10.1515/CCLM.2004.208 (Pubitemid 39307394)
7. Malaguarnera M., Pistone G., Motta M., Vinci E., Oreste G., Avellone G., Musumeci S., Elevated plasma total homocysteine in centenarians. Clinical Chemistry and Laboratory Medicine 2004 42 3 307 310 2-s2.0-1842787585 10.1515/CCLM.2004.056 (Pubitemid 38477527)
8. Dalton M., Williams J. S., How best to approach point-of-care testing. CAP Today 1997 11 12 46 50 2-s2.0-0031298895
9. Wang H., Yoshizumi M., Lai K., Tsai J.-C., Perrella M. A., Haber E., Lee M.-E., Inhibition of growth and p21(ras) methylation in vascular endothelial cells by homocysteine but not cysteine. Journal of Biological Chemistry 1997 272 40 25380 25385 2-s2.0-0030610589 10.1074/jbc.272.40.25380 (Pubitemid 27415732)
10. Selhub J., Jacques P. F., Bostom A. G., D'Agostino R. B., Wilson P. W. F., Belanger A. J., O'Leary D. H., Wolf P. A., Schaefer E. J., Rosenberg I. H., Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. The New England Journal of Medicine 1995 332 5 286 291 2-s2.0-0028966321 10.1056/NEJM199502023320502
11. Coull B. M., Malinow M. R., Beamer N., Sexton G., Nordt F., De Garmo P., Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990 21 4 572 576 2-s2.0-0025278455 (Pubitemid 20141879)
12. Hoogeveen E. K., Kostense P. J., Eysink P. E. D., Polak B. C. P., Beks P. J., Jakobs C., Dekker J. M., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Hyperhomocysteinemia is associated with the presence of retinopathy in type 2 diabetes mellitus: the Hoorn Study. Archives of Internal Medicine 2000 160 19 2984 2990 2-s2.0-0034706418 (Pubitemid 32009057)
13. Aydemir O., Türkçüoǧlu P., Güler M., Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy. Retina 2008 28 5 741 743 (Pubitemid 351655128)
14. Goldstein M., Leibovitch I., Yeffimov I., Gavendo S., Sela B.-A., Loewenstein A., Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy. Eye 2004 18 5 460 465 2-s2.0-2942682798 10.1038/sj.eye.6700702 (Pubitemid 38765315)
15. Cho H. C., The relationship among homocysteine, bilirubin, and diabetic retinopathy. Diabetes & Metabolism 2011 35 6 595 601
16. Welch G. N., Loscalzo J., Homocysteine and atherothrombosis. The New England Journal of Medicine 1998 338 15 1042 1050 2-s2.0-0032499024 10.1056/NEJM199804093381507 (Pubitemid 28180407)
17. Marrazzo G., Bosco P., la Delia F., Scapagnini G., Di Giacomo C., Malaguarnera M., Galvano F., Nicolosi A., Li Volti G., Neuroprotective effect of silibinin in diabetic mice. Neuroscience Letters 2011 504 3 252 256 2-s2.0-82455188100 10.1016/j.neulet.2011.09.041
18. Marrazzo G., Barbagallo I., Galvano F., Role of dietary and endogenous antioxidants in diabetes. Critical Reviews in Food Science and Nutrition 2014 54 12 1599 1616